Shekhat Denil Nanji
SEC insider (Form 3/4/5 filer). CIK 0002016605. Director at MIRA PHARMACEUTICALS, INC. (MIRA). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 12, 2026. Located in MIAMI, FL.
Companies Shekhat Denil Nanji has filed insider reports for
- MIRA PHARMACEUTICALS, INC. (MIRA): Director
Shekhat Denil Nanji
CIK: 0002016605
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MIRA
MIRA PHARMACEUTICALS, INC.
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 12, 2026MIRA
MIRA PHARMACEUTICALS, INC.
AwardDirectStock Options (right to buy)
50K shares- - Oct 1, 2025MIRA
MIRA PHARMACEUTICALS, INC.
AwardDirect22.4K shares at avg. $1.35$30K - Dec 9, 2024MIRA
MIRA PHARMACEUTICALS, INC.
AwardDirectStock Options (right to buy)
50K shares-
1-3 of 3 transactions